» Articles » PMID: 11127420

Abstinence Symptoms During Withdrawal from Chronic Marijuana Use

Overview
Specialty Pharmacology
Date 2000 Dec 29
PMID 11127420
Citations 61
Authors
Affiliations
Soon will be listed here.
Abstract

Although marijuana is the most commonly used illicit drug in the United States, it is not established whether withdrawal from chronic use results in a clinically significant abstinence syndrome. The present study was conducted to characterize symptoms associated with marijuana withdrawal following chronic use during a supervised 28-day abstinence period. Three groups of participants were studied: (a) current chronic marijuana users, (b) former chronic marijuana users who had not used marijuana for at least 6 months prior to the study, and (c) marijuana nonusers. Current users experienced significant increases in anxiety, irritability, physical tension, and physical symptoms and decreases in mood and appetite during marijuana withdrawal. These symptoms were most pronounced during the initial 10 days of abstinence, but some were present for the entire 28-day withdrawal period. These findings support the notion of a marijuana withdrawal syndrome in humans.

Citing Articles

"Weeding out" violence? Translational perspectives on the neuropsychobiological links between cannabis and aggression.

Bortolato M, Braccagni G, Pederson C, Floris G, Fite P Aggress Violent Behav. 2024; 78.

PMID: 38828012 PMC: 11141739. DOI: 10.1016/j.avb.2024.101948.


Lower dACC glutamate in cannabis users during early phase abstinence.

Zuo C, Davis K, Lukas S Neuropsychopharmacology. 2022; 47(11):1969-1975.

PMID: 35484401 PMC: 9485248. DOI: 10.1038/s41386-022-01321-5.


Changes in striatal dopamine release, sleep, and behavior during spontaneous Δ-9-tetrahydrocannabinol abstinence in male and female mice.

Kesner A, Mateo Y, Abrahao K, Ramos-Maciel S, Pava M, Gracias A Neuropsychopharmacology. 2022; 47(8):1537-1549.

PMID: 35478010 PMC: 9205922. DOI: 10.1038/s41386-022-01326-0.


Elevated striatal glutamate + glutamine in recreational cannabis users during abstinence.

Zuo C, Davis K, Kuppe M, Dahlgren M, Gruber S, Fitzmaurice G J Psychiatr Res. 2022; 146:192-200.

PMID: 34999370 PMC: 8803139. DOI: 10.1016/j.jpsychires.2021.12.041.


Assessment of Withdrawal, Mood, and Sleep Inventories After Monitored 3-Week Abstinence in Cannabis-Using Adolescents and Young Adults.

Sullivan R, Wallace A, Stinson E, Montoto K, Kaiver C, Wade N Cannabis Cannabinoid Res. 2021; 7(5):690-699.

PMID: 34678051 PMC: 9587800. DOI: 10.1089/can.2021.0074.